A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry Disease
Clinical trial NCT04974749 · COMPLETED
Trial details
- NCT number
- NCT04974749
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2024-01-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.